EVALUAR EL EFECTO DE DOS AÑOS DE TRATAMIENTO CON UN REGIMEN DE TRES DOSIS DIFERENTES DE NORDITROPIN SIMPLEXX EN LA TALLA DE NIÑOS CON RETRASO EN EL CRECIMIENTO INTRAUTERINO CON EDADES COMPRENDIDAS ENTRE 3 Y > 8 AÑOS EN EL MOMENTO DEL COMIENZO DEL TRATAMIENTO.

NR5A1/SF-1 Collaborates with Inhibin a and the Androgen Receptor

Elzenaty, Rawda Naamneh; (...); Fluck, Christa E

Article. 10.3390/ijms251810109. 2024

• 
• 
• 1

  

Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

Le Guen Y; (...); Rujescu D

Article. 10.1001/jamaneurol.2022.1166. 2022

• 
• 
• 61

  

Consensus guide on prophylactic gonadectomy in different sex development.

Guerrero-Fernandez, Julio; (...); Nistal, Manuel

Article. 10.1016/j.endien.2022.10.002. 2022

• 
• 5

  

Delphi consensus on the diagnosis and treatment of patients with short stature in Spain: GROW-SENS study.

Corripio-Collado, R.; (...); Labarta-Aizpun, I, J-

Letter. 10.1007/s40618-021-01696-0. 2022

• 
• 
• 3

  

Increased IGFBP proteolysis, IGF-I bioavailability and pappalysin levels in children with Prader-Willi syndrome.

Barrios V; (...); Argente J

Article. 10.1210/clinem/dgad754. 2023

• 
• 3

  

Towards an experimental proof of oligogenicity explaining a severe 46, XY DSD phenotype associated with heterozygote NR5A1/SF-1 variation

Naamneh-Elzenaty, Rawda; (...); Flueck, Christa E.

Meeting Abstract. 2024

Use of [(18)F]fluorocholine PET/CT in the detection of primary hyperparathyroidism in paediatrics: a case report.

Martínez Sánchez H; (...); Sánchez Vañó R

Case Reports. 10.1515/jpem-2023-0556. 2024